DECHRA VETERINARY PRODUCTS A/S: Financial statements 2024
CVR: 10114241
Source: annual report 2024, Danish Business Authority
01/07/2023 – 30/06/2024
DECHRA VETERINARY PRODUCTS A/S (CVR 10114241) has filed annual accounts for 2024. In 2024, the company reported revenue of DKK 2,680,690,000 and a net result of DKK 116,939,000 compared with DKK 129,704,000 the year before. That is an increase of 6.7% compared with the year before. The profit margin was 4.4%. Equity in the 2024 report amounted to DKK 631,669,000. The solvency ratio was 45.6%. The company had 108 employees in the financial year.
- Revenue
- DKK 2,680,690,000
- Gross Profit
- DKK 240,932,000
- Profit/Loss
- DKK 116,939,000
- Equity
- DKK 631,669,000
- Total Assets
- DKK 1,386,097,000
- Employees
- 108
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | 2.7B | 240.9M | 116.9M | 631.7M | 108 |
| 2023 | 2.5B | 238.9M | 129.7M | 688.9M | 110 |
| 2022 | 2.4B | 255.8M | 157.6M | 560.4M | 108 |
| 2021 | 2.1B | 192.2M | 98.3M | 403.1M | 98 |
| 2020 | 1.6B | 112M | 23.3M | 302.8M | 91 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
As of June 10, 2024, Milton McCann has joined the board of directors of DECHRA VETERINARY PRODUCTS A/S.
As of June 10, 2024, Ian David Page has left the board of directors of DECHRA VETERINARY PRODUCTS A/S.
As of June 10, 2024, Milton McCann is registered as director of DECHRA VETERINARY PRODUCTS A/S.
As of June 10, 2024, Ian David Page has stepped down as director of DECHRA VETERINARY PRODUCTS A/S.
About DECHRA VETERINARY PRODUCTS A/S
DECHRA VETERINARY PRODUCTS A/S is a Danish company of the type Aktieselskab based in Uldum, founded in 1986. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named VETXX A/S and LEO ANIMAL HEALTH A/S. The management consists of Ian Machan Mackellar. The board consists of Ajay Gandhi (chair), Ian Machan Mackellar and Robert Mark Leather. The company is owned by Dechra Pharmaceuticals Limited. The company has 122 employees (2026). In 2025, the company reported revenue of DKK 2,875,016,000 and a net result of DKK 189,967,000 compared with DKK 116,939,000 the year before. Equity in the 2025 report amounted to DKK 571,636,000.
